title: Genetic-based biomarkers and next-generation sequencing: the future of personalized care in colorectal cancer.
abstract: The past 5 years have witnessed extraordinary advances in the field of DNA sequencing technology. What once took years to accomplish with Sanger sequencing can now be accomplished in a matter of days with next-generation sequencing (NGS) technology. This has allowed researchers to sequence individual genomes and match combinations of mutations with specific diseases. As cancer is inherently a disease of the genome, it is not surprising to see NGS technology already being applied to cancer research with promises of greater understanding of carcinogenesis. While the task of deciphering the cancer genomic code remains ongoing, we are already beginning to see the application of genetic-based testing in the area of colorectal cancer. In this article we will provide an overview of current colorectal cancer genetic-based biomarkers, namely mutations and other genetic alterations in cancer genome DNA, discuss recent advances in NGS technology and speculate on future directions for the application of NGS technology to colorectal cancer diagnosis and treatment.
authors: Stanford Genome Technology Center, Stanford University, Stanford, CA, USA.
authors: Redecca Y
authors: RY
authors: Kim
authors: Hua
authors: H
authors: Xu
authors: Samuel
authors: S
authors: Myllykangas
authors: Hanlee
authors: H
authors: Ji
keywords: EGFR inhibition; adenocarcinoma; antineoplastic agents; biological analysis; biomarkers; cetuximab; colorectal neoplasms; etiology genetics; genomics; humans; panitumumab; sequencing; targeted therapies; tumor markers
references: Pharmacogenomics. 2009 Aug;10(8):1285-94
references: 19663673
references: Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19432-7
references: 19050079
references: J Clin Oncol. 2008 Apr 1;26(10):1626-34
references: 18316791
references: PLoS One. 2010 May 13;5(5):e10612
references: 20485525
references: Dis Colon Rectum. 2001 Apr;44(4):549-57
references: 11330582
references: Nature. 2008 Nov 6;456(7218):66-72
references: 18987736
references: Nat Rev Clin Oncol. 2010 Mar;7(3):153-62
references: 20142816
references: Cancer Res. 1998 Nov 15;58(22):5248-57
references: 9823339
references: J Clin Oncol. 2006 Nov 20;24(33):5313-27
references: 17060676
references: J Clin Oncol. 2010 Nov 1;28(31):4706-13
references: 20921462
references: J Clin Oncol. 2004 Feb 1;22(3):529-36
references: 14752076
references: Br J Cancer. 2010 Aug 10;103(4):581-9
references: 20628391
references: J Clin Oncol. 2008 Dec 10;26(35):5705-12
references: 19001320
references: Oncology (Williston Park). 2010 Jan;24(1 Suppl 1):9-13
references: 20225606
references: J Clin Oncol. 2005 Jan 20;23(3):609-18
references: 15659508
references: Nature. 2008 Apr 17;452(7189):872-6
references: 18421352
references: Ann N Y Acad Sci. 1995 Sep 30;768:101-10
references: 8526339
references: J Clin Oncol. 2010 Jul 10;28(20):3219-26
references: 20498393
references: Cold Spring Harb Symp Quant Biol. 2003;68:1-11
references: 15338597
references: Clin Cancer Res. 2005 Dec 1;11(23):8332-40
references: 16322293
references: Lancet Oncol. 2010 Aug;11(8):753-62
references: 20619739
references: N Engl J Med. 2008 Oct 23;359(17):1757-65
references: 18946061
references: Br J Cancer. 1999 Feb;79(5-6):903-8
references: 10070888
references: J Clin Oncol. 2010 Sep 20;28(27):4255-67
references: 20585100
references: Pharmacogenomics. 2009 Jun;10(6):961-9
references: 19530963
references: Nat Rev Genet. 2010 Jan;11(1):31-46
references: 19997069
references: Semin Oncol. 2007 Oct;34(5):435-43
references: 17920900
references: Nat Methods. 2009 Nov;6(11 Suppl):S2-5
references: 19844227
references: Gastroenterology. 1998 Jun;114(6):1188-95
references: 9609755
references: Biotechniques. 2009 Apr;46(5):351-2, 354-5
references: 19480630
references: J Clin Oncol. 2007 Mar 1;25(7):767-72
references: 17228023
references: N Engl J Med. 2001 Apr 19;344(16):1196-206
references: 11309634
references: Br J Clin Pharmacol. 2010 Jan;69(1):58-66
references: 20078613
references: N Biotechnol. 2009 Apr;25(4):195-203
references: 19429539
references: J Clin Oncol. 2009 Dec 10;27(35):5924-30
references: 19884556
references: Cold Spring Harb Symp Quant Biol. 2005;70:73-81
references: 16869740
references: Br J Cancer. 2005 Feb 14;92(3):434-44
references: 15668707
references: J Clin Oncol. 2005 Mar 1;23(7):1365-9
references: 15735113
references: J Clin Oncol. 2009 Jun 1;27(16):2622-9
references: 19398573
references: Nat Biotechnol. 2008 Oct;26(10):1135-45
references: 18846087
references: Eur J Cancer. 2009 Jul;45(10):1890-6
references: 19427194
references: J Clin Oncol. 2009 Apr 10;27(11):1814-21
references: 19273709
references: Nat Methods. 2009 Nov;6(11 Suppl):S13-20
references: 19844226
references: Genome Res. 2009 Sep;19(9):1622-9
references: 19470904
references: Br J Cancer. 2001 Sep 1;85(5):692-6
references: 11531254
references: Harv Law Rev. 2009 Jan;122(3):1038-45
references: 19288615
references: Lancet. 2007 Dec 15;370(9604):2020-9
references: 18083404
references: Nature. 2010 Jan 14;463(7278):184-90
references: 20016488
references: Eur J Cancer. 2010 Oct;46(15):2781-7
references: 20580219
references: PLoS One. 2009 Oct 02;4(10):e7287
references: 19806185
references: Cancer Res. 2007 Mar 15;67(6):2643-8
references: 17363584
references: Cancer Biol Ther. 2005 Aug;4(8):861-3
references: 16210915
references: Mol Biosyst. 2009 Sep;5(9):902-8
references: 19668850
references: J Natl Cancer Inst. 1998 May 6;90(9):675-84
references: 9586664
references: N Engl J Med. 2009 Apr 2;360(14):1408-17
references: 19339720
references: Nature. 2008 Nov 6;456(7218):53-9
references: 18987734
references: N Engl J Med. 2003 Jul 17;349(3):247-57
references: 12867608
references: N Engl J Med. 1988 Sep 1;319(9):525-32
references: 2841597
references: Nat Rev Cancer. 2003 May;3(5):330-8
references: 12724731
references: J Clin Oncol. 2010 Jan 20;28(3):466-74
references: 20008640
references: Med J Aust. 2000 Apr 3;172(7):313-6
references: 10844916
references: World J Gastroenterol. 2010 Jul 7;16(25):3133-43
references: 20593498
references: N Engl J Med. 2009 Sep 10;361(11):1058-66
references: 19657110
references: Lancet Oncol. 2005 May;6(5):301-10
references: 15863378
references: Int J Cancer. 1998 Aug 21;79(4):390-5
references: 9699532
references: Nature. 2002 Aug 29;418(6901):934
references: 12198537
references: J Natl Cancer Inst. 2010 Apr 7;102(7):464-74
references: 20233996
references: Oncogene. 2010 May 27;29(21):3033-43
references: 20383189
references: J Clin Oncol. 2008 Jan 20;26(3):374-9
references: 18202412
references: J Clin Oncol. 2010 May 20;28(15):2556-64
references: 20385995
references: J Clin Oncol. 2003 Mar 15;21(6):1174-9
references: 12637487
references: Nat Rev Genet. 2010 Oct;11(10):685-96
references: 20847746
references: Cancer Cell. 2010 May 18;17(5):443-54
references: 20478527
references: J Clin Oncol. 2009 Feb 10;27(5):663-71
references: 19114683
references: Genome Res. 2010 Apr;20(4):413-27
references: 20179022
references: J Clin Oncol. 2010 Jan 10;28(2):264-71
references: 19949014
references: Cancer. 1997 Jan 15;79(2):233-44
references: 9010096
references: J Clin Oncol. 2003 Jun 15;21(12):2397-406
references: 12692171
references: N Engl J Med. 2009 Feb 5;360(6):563-72
references: 19196673
references: Science. 2007 Nov 16;318(5853):1108-13
references: 17932254
references: Nat Rev Genet. 2009 Sep;10(9):617-27
references: 19687803